There is no mention of “SMMT” or any related new product development in the provided context. The context discusses topics such as:
1. Integration efforts for SMB technology platforms like Cabbage Center
2. Embryo Pharmaceuticals’ Series B financing for Ninerifaxtat (NHCM treatment)
3. Business development strategies at Biogen
4. Consumer confidence, FICO scores, and SMB e-commerce exposure
5. Yihang General Aviation’s progress in unmanned passenger aircraft standards
If “SMMT” refers to a specific entity or product, it is not covered in the available context.